Reuters logo
BRIEF-Oncolytics Biotech Inc reports qtrly share of $0.02
November 8, 2017 / 3:55 PM / 12 days ago

BRIEF-Oncolytics Biotech Inc reports qtrly share of $0.02

Nov 8 (Reuters) - Oncolytics Biotech Inc:

* Oncolytics Biotech Inc. announces 2017 third quarter results

* ‍At September 30, 2017, company reported $14.0 million in cash and cash equivalents; cash runway expected to end of 2018​

* Oncolytics Biotech Inc qtrly ‍basic and diluted loss per common share $0.02​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below